Therefore, all downloaded ICSRs already included semaglutide among the suspected medicinal products, regardless of the specific brand name or pharmaceutical formulation reported
For patients with significant obesity and weight-related complications who cannot tolerate pharmacological options, bariatric surgery may be considered according to NICE criteria (typically BMI 40 kg/m, or 35 kg/m with comorbidities, with lower thresholds for people with recent-onset type 2 diabetes)
February 17, 2025 16:44 View More Is Your Thyroid Really the Problem
Tirzepatide is a dual GIP/GLP-1 receptor agonist that improves blood sugar control and promotes weight loss through multiple metabolic pathways
Personalized Consultation Your journey begins with a thorough consultation where our experienced healthcare providers will assess your medical history, current health status, and weight loss goals